ÂÜÀòÂÒÂ×

Wendy Blanda, PhD, is a seasoned expert in pharmaceutical and biotech product development, currently serving as the Company Owner and Principal Consultant at Blanda and Associates, LLC. Since January 2023, responsibilities have included formulation development troubleshooting, regulatory interactions, project management, and drug-device combination products development. In addition, Wendy Blanda holds multiple consulting roles, including Acting Senior Director of Product Development at 3Daughters and Consultant for Atheln, Inc. From 2013 to 2019, significant experience was gained at the International Partnership for Microbicides and prior roles included Director positions at SpyGlass Pharma, Titan Pharmaceuticals, and Allergan. Educational credentials include a PhD in Macromolecular Science and Engineering from the University of Michigan and an MS in Engineering Management from California State University, Northridge.